On Friday, Shares of PharmAthene, Inc. (NYSEMKT:PIP), included 5.17% and shut at $3.05 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $2.95 and $3.12. The business’ commercial center capitalization is $214.05 million with the aggregate fabulous loads of 66.73 million. PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against anthrax, recently declared that its Board of Directors has declared a special one-time cash dividend of $2.91 per share of common stock, payable on February 3, 2017 to holders of record as of January 24, 2017.
The special dividend, totaling an aggregate payment of about $200 million, which represents about 98% of the after tax net cash proceeds received from SIGA, was approved by PharmAthene’s Board of Directors following the Company’s receipt of $83.9 million as final payment from SIGA Technologies, Inc. in satisfaction of the judgment owed by it to PharmAthene. In total, PharmAthene has received payment of about $217 million (counting interest) from SIGA in connection with the judgment.
Specialized assessment: During the fifty two-week exchanging session the negligible rate at which extent cost exchanged, enrolled at $1.38 and came to max level of $3.12. The EPS of organization is walking around 1.74.
Shares of Post Holdings Inc (NYSE:POST), subtract -3.22% and shut at $72.34 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $69.10 and $77.47. The association’s commercial center capitalization is $4.65 Billion with the general uncommon loads of 64.65 million. Post Holdings, Inc. (POST), a consumer packaged goods holding company, recently stated results for the fourth quarter and fiscal year ended September 30, 2016.
Fourth Quarter net sales of $1.3 billion; operating profit of $108.3 million; net loss of ($37.0) million and Adjusted EBITDA of $219.5 million
Fiscal Year net sales of $5.0 billion; operating profit of $545.7 million; net loss of ($3.3) million and Adjusted EBITDA of $933.9 million
Fiscal 2017 Adjusted EBITDA (non-GAAP) guidance range of $910-$950 million
Fourth Quarter Merged Operating Results
Net sales were $1,260.8 million, a decline of $49.0 million, or 3.7%, contrast to the prior year. On a comparable basis, net sales declined 6.0% when contrast to the same period in fiscal 2015 mainly resulting from an anticipated decline in sales within the Michael Foods Group segment.
Specialized examination: All through the fifty two-week exchanging session the negligible expense at which extent cost exchanged, enlisted at $50.93 and came to max level of $89.00. The EPS of association is by walking at -0.41.